Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Post-Stroke Aphasia TMS

NCT: NCT06974279 · RECRUITING

NCT IDNCT06974279
StatusRECRUITING
Start Date2025-09-01
Completion2036-12-31
SponsorMedical College of Wisconsin (OTHER)
First posted
Last updated

Brief Summary

The investigator proposes to examine the effects of excitatory transcranial magnetic stimulation (TMS) combined with semantic feature analysis (SFA) language therapy to improve word-finding abilities in stroke survivors with aphasia (SWA).

Frequently Asked Questions

What is Post-Stroke Aphasia TMS?

Post-Stroke Aphasia TMS is a clinical trial registered under NCT06974279. Current status: RECRUITING.

What is the status of NCT06974279?

The current status of NCT06974279 (Post-Stroke Aphasia TMS) is: RECRUITING.

When did Post-Stroke Aphasia TMS start?

Post-Stroke Aphasia TMS started on 2025-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.